The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVp Regulatory News (VP.)

Share Price Information for Vp (VP.)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 675.00
Bid: 665.00
Ask: 690.00
Change: 5.00 (0.75%)
Spread: 25.00 (3.759%)
Open: 670.00
High: 690.00
Low: 660.00
Prev. Close: 670.00
VP. Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8 (OPD) - Vp PLC

12 May 2022 12:55

RNS Number : 3125L
Vp PLC
12 May 2022
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Vibroplant Trustees Limited (as nominee for the Vp Employee Trust)

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

Vp Employee Trust

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Vp plc

(d) Is the discloser the offeror or the offeree?

N/A

(e) Date position held:

The latest practicable date prior to the disclosure

12 May 2022

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

Ordinary shares of 5p each

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

499,774

1.24%

Nil

Nil

(2) Cash-settled derivatives:

 

Nil

-

Nil

-

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

-

Nil

-

 

TOTAL:

499,774

1.24%

Nil

-

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

Nil

Details, including nature of the rights concerned and relevant percentages:

Nil

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

 

None

 

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

12 May 2022

Contact name:

Allison Bainbridge, Group Finance Director

Telephone number:

+44 (0)1423 533 445

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEEGPUWAAUPPGGP
Date   Source Headline
16th Apr 20247:00 amRNSTrading Update
5th Feb 20243:26 pmRNSNotification of Major Holdings
28th Nov 20237:00 amRNSInterim Results
23rd Nov 20237:00 amRNSInvestor Presentation with Equity Development
22nd Nov 20237:00 amRNSPresentation via Investor Meet Company
2nd Nov 20237:00 amRNSBoard Appointment
11th Oct 20237:00 amRNSTrading Update & Notice of Interim Results
11th Aug 20237:00 amRNSBoard Changes
25th Jul 20232:57 pmRNSDirector/PDMR Shareholding
20th Jul 20231:11 pmRNSResult of Annual General Meeting
20th Jul 20237:00 amRNSAGM Statement
9th Jun 20233:44 pmRNSDirector/PDMR Shareholding
7th Jun 20237:00 amRNSFinal Results
26th May 20237:00 amRNSInvestor Presentation with Equity Development
25th May 20237:00 amRNSPresentation via Investor Meet Company
24th May 20237:00 amRNSNotice of Final Results
13th Apr 20237:00 amRNSTrading Update
8th Dec 20224:40 pmRNSSecond Price Monitoring Extn
8th Dec 20224:35 pmRNSPrice Monitoring Extension
5th Dec 20224:40 pmRNSSecond Price Monitoring Extn
5th Dec 20224:35 pmRNSPrice Monitoring Extension
29th Nov 20227:01 amRNSBoard Changes
29th Nov 20227:00 amRNSInterim Results
18th Nov 20227:00 amRNSPresentation via Equity Development
16th Nov 20227:00 amRNSPresentation via Investor Meet Company
10th Nov 20224:36 pmRNSPrice Monitoring Extension
11th Oct 20227:00 amRNSTrading Update and Notice of Interim Results
7th Oct 20221:32 pmRNSDirector/PDMR Shareholding
7th Oct 202211:31 amRNSHolding(s) in Company
23rd Aug 20224:59 pmRNSDirector/PDMR Shareholding
23rd Aug 20224:59 pmRNSDirector/PDMR Shareholding
23rd Aug 20224:50 pmRNSDirector/PDMR Shareholding
22nd Aug 202211:12 amRNSForm 8.5 (EPT/RI)
19th Aug 202211:20 amRNSForm 8.5 (EPT/RI)
18th Aug 202211:53 amRNSForm 8.5 (EPT/RI)
17th Aug 20229:28 amRNSForm 8.5 (EPT/RI)
16th Aug 20229:57 amRNSForm 8.5 (EPT/RI)
15th Aug 20226:28 pmRNSConclusion of Formal Sale Process
15th Aug 202210:21 amRNSForm 8.5 (EPT/RI)
12th Aug 202210:03 amRNSForm 8.5 (EPT/RI)
11th Aug 202210:02 amRNSForm 8.5 (EPT/RI)
10th Aug 20222:58 pmRNSForm 8.3 - VP plc
10th Aug 202211:52 amRNSForm 8.3 - Vp plc
10th Aug 202211:50 amRNSForm 8.5 (EPT/RI)
3rd Aug 202212:14 pmRNSForm 8.3 - VP PLC
2nd Aug 20222:36 pmRNSForm 8.3 - VP PLC
2nd Aug 20221:21 pmRNSForm 8.3 - [Vp plc]
2nd Aug 202210:03 amRNSForm 8.5 (EPT/RI)
29th Jul 20222:42 pmRNSForm 8.3 - VP plc
29th Jul 20221:33 pmRNSForm 8.3 - [Vp plc]

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.